Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERLOTINIB vs ERTAPENEM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERLOTINIB vs ERTAPENEM: Safety Overview

Metric ERLOTINIB ERTAPENEM
Total FAERS Reports 22,472 4,069
Deaths Reported 6,791 223
Death Rate 30.2% 5.5%
Hospitalizations 3,693 1,617
Average Patient Age 67.2 yrs 64.1 yrs
% Female Patients 59.8% 54.5%
FDA Approval Date Apr 16, 2020 Apr 16, 2018
Manufacturer Zydus Lifesciences Limited Merck Sharp & Dohme LLC
Route ORAL INTRAMUSCULAR
Marketing Status Discontinued Prescription